All In Biotech

Drug Trial Radar · NCT07325292

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

A Randomized, Phase 3, Open-label Study to Investigate Pharmacokinetics, Safety, and Efficacy of Subcutaneous Compared to Intravenous Frexalimab in Adult Participants With Multiple Sclerosis

Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

160

Planned (sponsor's estimate)

Start

Jan 14, 2026

Primary completion

Jul 15, 2027

Study completion Nov 30, 2028

Sponsor

Lead sponsor
SanofiSanofi (SNY)
Sponsor type
Industry
First posted
Jan 8, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, open-label, parallel, Phase 3 study with 2-arms for treatment. The purpose of this study is to evaluate SC administration of frexalimab every 4 weeks (q4w) compared to IV administration of frexalimab q4w in male and female participants with RMS and nrSPMS (aged 18 to 60 years at the time of enrollment). People diagnosed with MS are eligible for enrollment as long as they meet all the inclusion criteria and none of the exclusion criteria. Study details include: The study intervention duration will be 48 weeks (12 months) for Parts A and B combined. Optional Part C will last until the initiation of a long term safety study for Frexalimab.The follow up duration after the end of study intervention (in case of discontinuation) will be 6 months. The number of scheduled visits (Parts A and B) will be 17 for participants receiving frexalimab SC or IV, with an on-site visit frequency of every month between Week 4 and Week 24 in Part A, then every 1 to 3 months in Part B, then every 6 months in Part C. Participants discontinuing treatment before the End of Study will have an additional 3 follow-up visits.

Conditions

  • Multiple Sclerosis

Interventions

  • FrexalimabDrug

    Pharmaceutical form:Solution for injection-Route of administration:SC injection

  • FrexalimabDrug

    Pharmaceutical form:Concentrate for solution for infusion-Route of administration:IV infusion

  • MRI contrast-enhancing preparationsDrug

    Route of administration:IV injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area under the curve over the interval W20 to W24(part A)Time frame: Until Week 24
  2. Trough concentration at steady state(part A)Time frame: Until Week 24

Locations

68 sites in 7 countries. Site status is shown where the registry gives one.

  • North Central Neurology Associates- Site Number : 8401100

    Cullman, Alabama · Recruiting

  • Alabama Neurology Associates- Site Number : 8400115

    Homewood, Alabama · Recruiting

  • Center for Neurology and Spine - Phoenix - East Bell Road- Site Number : 8400195

    Phoenix, Arizona · Recruiting

  • Perseverance Research Center- Site Number : 8400138

    Scottsdale, Arizona · Recruiting

  • Center for Neurosciences - Tucson- Site Number : 8400194

    Tucson, Arizona · Recruiting

  • Chemidox Clinical Trials- Site Number : 8401157

    Lancaster, California · Recruiting

  • Private Practice - Dr. Regina Berkovich- Site Number : 8400005

    West Hollywood, California · Recruiting

  • Rocky Mountain Regional VA Medical Center- Site Number : 8400121

    Aurora, Colorado · Recruiting

  • Advanced Neurology of Colorado- Site Number : 8400148

    Fort Collins, Colorado · Recruiting

  • Neurology of Central Florida- Site Number : 8400147

    Altamonte Springs, Florida · Recruiting

  • Norman Fixel Institute for Neurological Diseases (FIND)- Site Number : 8400054

    Gainesville, Florida · Recruiting

  • Aqualane Clinical Research- Site Number : 8400026

    Naples, Florida · Recruiting

  • Orlando Health Neuroscience Institute - Downtown Pavilion- Site Number : 8400060

    Orlando, Florida · Recruiting

  • Neurology Associates of Ormond Beach- Site Number : 8400086

    Ormond Beach, Florida · Recruiting

  • University of South Florida- Site Number : 8400013

    Tampa, Florida · Recruiting

  • Palm Beach Neurology- Site Number : 8400105

    West Palm Beach, Florida · Recruiting

  • Atlanta Neuroscience Institute- Site Number : 8400075

    Atlanta, Georgia · Recruiting

  • Joi Life Wellness Group Llc- Site Number : 8400192

    Smyrna, Georgia · Recruiting

  • Consultants in Neurology- Site Number : 8400020

    Northbrook, Illinois · Recruiting

  • Baltimore Veterans Affairs Medical Center- Site Number : 8400163

    Baltimore, Maryland · Recruiting

  • Neurology Center of New England- Site Number : 8400164

    Foxborough, Massachusetts · Recruiting

  • Michigan Institute for Neurological Disorders- Site Number : 8400004

    Farmington Hills, Michigan · Recruiting

  • Holy Name Medical Center- Site Number : 8400101

    Teaneck, New Jersey · Recruiting

  • Piedmont HealthCare - Lake Norman Neurology- Site Number : 8400002

    Charlotte, North Carolina · Recruiting

  • Raleigh Neurology Associates- Site Number : 8400014

    Raleigh, North Carolina · Recruiting

  • The Ohio State University- Site Number : 8400009

    Columbus, Ohio · Recruiting

  • The Boster Center for Multiple Sclerosis- Site Number : 8400006

    Columbus, Ohio · Recruiting

  • Abington Neurological Associates- Site Number : 8401065

    Abington, Pennsylvania · Recruiting

  • Hope Neurology- Site Number : 8400019

    Knoxville, Tennessee · Recruiting

  • ANESC Research- Site Number : 8400187

    El Paso, Texas · Recruiting

  • North Texas Institute of Neurology & Headache - Plano- Site Number : 8400082

    Plano, Texas · Recruiting

  • North Texas Institute of Neurology & Headache - Plano- Site Number : 8400083

    Plano, Texas · Recruiting

  • Neurology Center of San Antonio- Site Number : 8400099

    San Antonio, Texas · Recruiting

  • Medical College of Wisconsin - Milwaukee Campus- Site Number : 8400038

    Milwaukee, Wisconsin · Recruiting

  • Investigational Site Number : 0560001

    Bruges, Belgium · Recruiting

  • Investigational Site Number : 0560008

    Brussels, Belgium · Recruiting

  • Investigational Site Number : 0560006

    Ghent, Belgium · Recruiting

  • Investigational Site Number : 0560007

    Kortrijk, Belgium · Recruiting

  • Investigational Site Number : 0560005

    Overpelt, Belgium · Recruiting

  • L2IP - Instituto de Pesquisas Clínicas- Site Number : 0760003

    Brasília, Federal District, Brazil · Recruiting

Showing 40 of 68 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.